Showing 1-10 of 332 grants

Title Institution Researcher Program Duration Total Award Amount
GNTI-122 for the treatment of recently diagnosed type 1 diabetes GentiBio Mark Bach Cures 01-December-2025 to 30-November-2027 $4,000,000.00
Collaboration for Global T1D Care Acora Rebecca Goldman Mission 01-December-2025 to 31-January-2027 $570,000.00
Advancing Breakthroughs in Type 1 Diabetes Research with Safe and Immune Cloaked Stem Cells Pluristyx Benjamin Fryer Cures 15-November-2025 to 14-November-2027 $704,860.20
Programming Pancreatic Cell Replacement Therapeutics Using Cellgorithm Technology Syntax Bio, Inc Ryan Clarke Cures 15-November-2025 to 14-November-2027 $856,250.00
Modes of action of a beta cell targeted prodrug for preventing and treating type 1 diabetes UT Southwestern Wen-hong Li Cures 01-November-2025 to 31-October-2028 $990,000.00
Engineering fully vascularized SC-islets through endothelial integration and endocrine-vascular crosstalk Boston Children's Hospital Juan Melero-Martin Cures 01-November-2025 to 31-October-2027 $599,994.46
Exploring Immunologic Mechanisms of Indirect (Encapsulated) Islet Graft Rejection Johns Hopkins University Joshua Doloff Cures 01-November-2025 to 31-October-2028 $1,125,000.00
Pseudohypoxia to improve SC-beta engraftment The Regents of the University of California, San Francisco Qizhi Tang Cures 01-October-2025 to 30-September-2027 $600,000.00
Hydrogels for Islet Engraftment in the Porcine Subcutaneous Space Georgia Tech Research Corporation Andres Garcia Cures 01-November-2025 to 31-October-2028 $771,544.57
Towards non-invasive imaging and improvement of islet engraftment via vascularization and oxygenation Arizona Board of Regents, University of Arizona Klearchos Papas Cures 01-October-2025 to 30-September-2027 $897,151.29